Cargando…
A Randomized, Single-Ascending-Dose, Ivermectin-Controlled, Double-Blind Study of Moxidectin in Onchocerca volvulus Infection
BACKGROUND: Control of onchocerciasis as a public health problem in Africa relies on annual mass ivermectin distribution. New tools are needed to achieve elimination of infection. This study determined in a small number of Onchocerca volvulus infected individuals whether moxidectin, a veterinary ant...
Autores principales: | Awadzi, Kwablah, Opoku, Nicholas O., Attah, Simon K., Lazdins-Helds, Janis, Kuesel, Annette C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072596/ https://www.ncbi.nlm.nih.gov/pubmed/24968000 http://dx.doi.org/10.1371/journal.pntd.0002953 |
Ejemplares similares
-
Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection
por: Tan, Beesan, et al.
Publicado: (2022) -
Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch
por: Awadzi, K., et al.
Publicado: (2015) -
Phenotypic Evidence of Emerging Ivermectin Resistance in Onchocerca volvulus
por: Osei-Atweneboana, Mike Y., et al.
Publicado: (2011) -
Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial
por: Opoku, Nicholas O, et al.
Publicado: (2018) -
The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data
por: Turner, Hugo C, et al.
Publicado: (2015)